Intended for healthcare professionals

Rapid response to:

Editorials

WHO downgrades status of oseltamivir

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3266 (Published 12 July 2017) Cite this as: BMJ 2017;358:j3266

Rapid Response:

Re: WHO downgrades status of oseltamivir

In practice it seemed useless at ameliorating flu severity or duration
Some people had significant adverse reactions
'Swine flu' with hindsight was no worse than 'ordinary flu' as per epidemic a few years prior.
Secondary infections in vulnerable more appropriately treated with antibiotics than relying on tamiflu
Again in hindsight a huge fuss over nothing and waste of money

Competing interests: No competing interests

13 July 2017
V Jane Philip
GP
London